Invasive pulmonary aspergillosis among ICU patients with COVID-19, influenza, and preexisting host factors: a nationwide cohort study. [PDF]
BMC Infect DisJeon N, Park M, Baek MS, Kim TW, Kim WY.
europepmc +1 more source
Development and validation of an interpretable machine learning model for the early diagnosis of invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: a retrospective cohort study. [PDF]
Front Cell Infect MicrobiolDing S +5 more
europepmc +1 more source
Correction to "Clinical Features and Predictive Risk Factors for Prognosis in Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis". [PDF]
Clin Respir Jeuropepmc +1 more source
Fine particulate matter control as a potential prevention measure for invasive pulmonary aspergillosis. [PDF]
EBioMedicineGuo C.
europepmc +1 more source
Efficacy of voriconazole combined with caspofungin in treating Chronic Obstructive Pulmonary Disease patients with invasive pulmonary aspergillosis: impacts on clinical outcomes, inflammatory cytokines, and immune markers. [PDF]
Front ImmunolZhang J, Huang Z.
europepmc +1 more source
Invasive pulmonary aspergillosis in the post-COVID-19 era: diagnosis, treatment, and what lies ahead. [PDF]
Ther Adv Infect DisNguyen Hai C.
europepmc +1 more source
Related searches:
Invasive Pulmonary Aspergillosis
Respiration, 2002<i>Background:</i> Invasive pulmonary aspergillosis usually occurs in immunocompromised patients. Mild abnormality of host defence is usually present in the chronic necrotising form of the disease. Acute aspergillus pneumonia usually affects patients who are seriously immunocompromised.
Sabina Skrgat, Kristan +2 more
+7 more sources
Invasive pulmonary aspergillosis/pseudomonas
BMJ Case Reports, 2021A 47-year-old Caucasian man on long-standing antifungal therapy for chronic necrotising aspergillosis and a history of recurrent pseudomonas pneumonias presented to the outpatient pulmonary clinic with dyspnoea and chest discomfort for 3 days. A CT angiography of the chest demonstrated angioinvasion from the previously noted left upper lobe cavitary ...
Menaka Mahendran, Daniel Urbine
openaire +2 more sources
Invasive Pulmonary Aspergillosis
Seminars in Respiratory and Critical Care Medicine, 2004Invasive pulmonary aspergillosis (IPA) is the most common fungal pulmonary infection in severely immunocompromised patients. Aspergillus species are commonly isolated from the soil, plant debris, and the indoor environment, including the hospital. Phagocytosis is the main host defense against Aspergillus conidia and hyphae.
Raoul, Herbrecht +3 more
openaire +2 more sources
Invasive Pulmonary Aspergillosis
JAMA: The Journal of the American Medical Association, 1980To the Editor:— In reference to the article "Invasive Pulmonary Aspergillosis Associated With Influenza" by Fischer and Walker (241:1493, 1979), mention is made that invasive pulmonary aspergillosis is usually seen in the compromised host and that invasive disease is rare in normal persons. The authors mention only 13 cases of pulmonary aspergillosis
openaire +2 more sources